Primary liver cancers are frequently accompanied by rearrangements of metabolic pathways. This Review discusses the role of metabolic liver disruptions and the implications of these processes, emphasizing their clinical relevance and value in early diagnosis and prognosis and as putative therapeutic targets.
- Letizia Satriano
- Monika Lewinska
- Jesper B. Andersen